A sildenafil expiration date marks the end of the shelf-life period supported for a specific finished drug product when it has been stored under its labeled conditions. FDA describes expiration dating in terms of continued strength, quality and purity rather than as a prediction that the medicine changes suddenly on one calendar day.
There is no single universal shelf life that can be assigned to every sildenafil product. The relevant date belongs to the specific manufacturer, formulation, package and lot, while some formulations can also acquire a separate in-use or discard-after period after preparation.
This distinction is especially important for sildenafil because current products include tablets, oral films and liquid formulations with different storage and handling instructions. This page explains how the printed expiration date, labeled storage conditions and formulation-specific discard periods should be interpreted together.
A sildenafil expiration date identifies the end of the period for which the manufacturer has stability data supporting the finished product under its labeled storage conditions. FDA describes this stability in terms of maintaining applicable standards of strength, quality and purity.
The expiration date does not mean sildenafil is known to lose all potency immediately after midnight on that date. Instead, it marks the boundary of the currently supported labeled shelf life unless an expiration extension has been formally supported by additional stability data.
The date is product-specific. Two sildenafil products can contain the same active ingredient while having different expiration dates because their manufacturers, formulations, packaging systems, manufacturing dates and stability data differ.
| Term | Meaning |
|---|---|
| Expiration date | End of the currently supported labeled shelf-life period for a specific finished product. |
| Shelf life | Period during which stability data support required product quality under labeled storage conditions. |
| Stability | Maintenance of applicable strength, quality and purity specifications over time. |
| Discard-after period | A separate formulation-specific in-use limit that can begin after preparation or reconstitution. |
Expiration dating is based on pharmaceutical stability studies rather than on an estimate derived from sildenafil's pharmacological half-life or duration of action. Those clinical pharmacology parameters operate on a scale of hours, whereas product stability concerns the quality of the manufactured dosage form over its shelf life.
Drug applicants submit stability data together with proposed expiration dating and storage conditions. FDA evaluates whether the proposed shelf life is supported by appropriate studies designed to show that the product continues to meet applicable quality standards.
Stability programs can also generate additional data after approval. FDA permits manufacturers to extend an approved product's expiration dating when the extension is supported by acceptable stability data and handled through the applicable regulatory process.
| Evaluation Element | Role |
|---|---|
| Stability studies | Track pharmaceutical quality over time. |
| Storage conditions | Define the environment under which shelf-life support applies. |
| Quality specifications | Set the standards the finished product must continue to meet. |
| Regulatory review | Determines whether proposed expiration dating is adequately supported. |
| Additional stability data | Can support a formal extension of expiration dating where applicable. |
Expiration and storage are inseparable parts of pharmaceutical stability. The expiration date assumes that the sildenafil product has been stored under the conditions described for that particular formulation.
For example, current U.S. generic ED sildenafil tablet labeling commonly specifies controlled room-temperature storage around 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). Current VIAGRA labeling similarly specifies 25°C with excursions from 15°C to 30°C.
Those temperatures illustrate the storage framework but should not be generalized to every sildenafil formulation. Liquid products, reconstituted preparations and individually packaged oral films can have their own instructions, so the specific product information remains authoritative.
| Concept | Sildenafil Context |
|---|---|
| Expiration | Defines the supported shelf-life endpoint. |
| Storage | Defines conditions under which that shelf-life support applies. |
| Typical current tablet storage | Controlled room temperature around 20°C to 25°C, with permitted excursions to 15°C to 30°C depending on the label. |
| Incorrect storage | Can compromise product quality before the printed expiration date. |
Expired sildenafil is a finished product that has passed the expiration date assigned to that specific package or lot. At that point, it is outside the shelf-life period currently supported by the product's labeled stability data.
Passing the expiration date does not establish that every tablet or film has suddenly become chemically inactive. It means the manufacturer-supported assurance that the product continues to meet its labeled strength, quality and purity specifications no longer extends beyond that point unless an official extension applies.
FDA notes more generally that degraded expired medicines may have lower strength than intended and that degradation can potentially create unwanted compounds. The condition of an individual expired sildenafil product therefore cannot be determined reliably from appearance or calendar age alone.
| Situation | Interpretation |
|---|---|
| Before expiration and properly stored | Within the product's supported labeled shelf life. |
| After expiration | Outside the currently supported shelf-life period. |
| Poorly stored before expiration | Quality can potentially be affected despite the printed date. |
| Officially extended expiration | Possible only where adequate supporting stability data and regulatory provisions apply. |
The expiration date does not provide a scientifically justified percentage of potency remaining afterward. It is therefore inappropriate to assume that sildenafil retains a particular fraction of its labeled strength for a specified number of months or years beyond expiration without product-specific stability evidence.
The opposite assumption is also too strong: an expiration date does not demonstrate that potency instantly falls to zero. What changes is the evidentiary status of the product — its labeled shelf-life support has ended.
FDA also recognizes that expiration dates can sometimes be extended when additional testing supplies acceptable supporting data. Such formal extensions are different from a consumer assuming that an expired product remains equivalent to an in-date product.
| Question | Evidence-Based Interpretation |
|---|---|
| Is labeled quality assured indefinitely after expiration? | No. |
| Does potency necessarily become zero on the expiration date? | No such conclusion follows from the date itself. |
| Can a universal percentage of remaining potency be assumed? | No. |
| Can expiration dating ever be extended? | Yes, when adequate additional stability data support a formal extension. |
Shelf-life data apply to products maintained under their labeled conditions. Exposure to excessive heat, freezing where prohibited, moisture or other unsuitable environmental conditions can undermine the assumptions on which expiration dating is based.
Current sildenafil tablets commonly use controlled room-temperature storage. REVATIO powder for oral suspension has different instructions: before reconstitution it should be stored below 30°C (86°F) in the original package to protect it from moisture.
After REVATIO oral suspension is reconstituted, the instructions change again. The mixed suspension can be stored below 30°C or refrigerated at 2°C to 8°C (36°F to 46°F), must not be frozen and has a 60-day in-use shelf life.
| Storage Factor | Sildenafil Example |
|---|---|
| Temperature | Current tablet products commonly specify controlled room-temperature conditions. |
| Moisture protection | REVATIO powder for oral suspension is stored in its original package to protect from moisture. |
| Refrigeration | Permitted for reconstituted REVATIO oral suspension at 2°C to 8°C. |
| Freezing | Reconstituted REVATIO oral suspension should not be frozen. |
| Time after preparation | Reconstituted REVATIO suspension is discarded 60 days after reconstitution. |
VIAGRA has product-specific expiration dating because the finished tablets, excipients, manufacturing process and packaging system are evaluated as a complete pharmaceutical product rather than as sildenafil citrate in isolation.
Current U.S. VIAGRA prescribing information specifies storage at 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). The specific expiration date for an individual package is tied to that manufactured product and lot.
VIAGRA expiration information should therefore not be transferred automatically to generic sildenafil, PAH-oriented sildenafil products or newer formulations such as oral film simply because all contain the sildenafil active moiety.
| VIAGRA Element | Interpretation |
|---|---|
| Active moiety | Sildenafil |
| Finished product | VIAGRA film-coated tablet formulation |
| Current labeled storage | 25°C, with permitted excursions from 15°C to 30°C |
| Expiration date | Specific to the finished manufactured product and lot |
Approved generic sildenafil products contain the same active moiety within the relevant regulatory framework, but their finished-product stability data remain manufacturer-specific. Generic approval does not assign every sildenafil tablet one universal expiration period.
Current generic sildenafil tablet labels frequently specify storage at 20°C to 25°C or at 25°C, with excursions permitted from 15°C to 30°C. Small differences in wording do not make one manufacturer's printed expiration date transferable to another manufacturer's package.
Manufacturer, formulation, excipients, packaging configuration and production lot all form part of the finished-product context. The expiration information printed for the actual dispensed product should therefore be used rather than a shelf-life estimate found for another sildenafil product.
| Factor | Why It Matters |
|---|---|
| Manufacturer | Maintains product-specific stability data. |
| Formulation and excipients | Form part of the finished-product stability system. |
| Container / packaging | Helps maintain defined environmental protection. |
| Lot | Connects the manufactured supply to its assigned expiration dating. |
Sildenafil formulation can materially change how shelf-life information is interpreted. A finished tablet or sealed oral film generally remains under its manufacturer-assigned expiration dating until use, while a preparation that must be reconstituted can acquire an additional in-use limit once mixed.
REVATIO oral suspension is the clearest current example. Before reconstitution, the powder follows its packaged-product storage instructions. After a pharmacist reconstitutes it to 10 mg/mL, the mixed suspension has a shelf life of 60 days and any remaining portion should be discarded after that period.
Current sildenafil oral films such as VYBRIQUE are supplied in individually sealed foil pouches and use controlled room-temperature storage. Their packaging and stability framework differ from both conventional tablets and reconstituted suspension, reinforcing why dosage form matters.
| Formulation | Expiration / In-Use Context |
|---|---|
| Film-coated tablet | Follow the expiration date and storage conditions for the specific finished product. |
| Oral film | Individually sealed product with its own manufacturer expiration and storage conditions. |
| Powder for oral suspension | Packaged shelf life applies before reconstitution. |
| Reconstituted REVATIO suspension | Separate 60-day shelf life begins after reconstitution. |
| Injection | Use the storage, container and expiration information for the specific parenteral product. |
The exact expiration date relevant to an individual sildenafil supply is the date assigned to that manufactured product or dispensing package, while prescribing information explains the product's approved storage and handling requirements.
Those sources answer different but connected questions. The expiration date identifies the supported shelf-life endpoint, while the storage section explains the environmental conditions assumed by the stability data.
Some formulations add a third date concept. REVATIO patient labeling instructs users to follow the 'Discard after' date written on the reconstituted suspension bottle because its 60-day in-use period begins when the pharmacist mixes the product.
| Source or Date | Purpose |
|---|---|
| Expiration date on product package | Identifies the shelf-life endpoint assigned to that supply. |
| Prescribing information | Provides approved storage and handling requirements. |
| Patient / dispensing label | Can provide product-specific handling or discard information. |
| REVATIO 'Discard after' date | Tracks the 60-day period after oral suspension reconstitution. |
Expiration is principally a pharmaceutical quality and stability issue. It does not replace sildenafil's clinical safety framework, which includes contraindications, warnings, adverse reactions and drug interactions.
Conversely, an in-date package is not automatically appropriate for every person. Being within shelf life says that the product remains inside its supported stability period when properly stored; it does not determine whether sildenafil is clinically appropriate in a particular situation.
Expired or improperly stored medicine adds a separate quality question on top of those normal clinical considerations. Product condition, clinical appropriateness and medication safety should therefore remain distinct concepts.
| Topic | Dedicated Resource |
|---|---|
| Side effects | Sildenafil Side Effects Guide |
| Warnings | Sildenafil Warnings & Precautions |
| Interactions | Sildenafil Drug Interactions |
| Storage | Sildenafil Storage & Handling |
Yes. Each finished sildenafil product has expiration dating supported by stability data for that specific product and its labeled storage conditions.
It marks the end of the currently supported shelf-life period during which the finished product is expected to meet applicable strength, quality and purity specifications when stored according to its labeling.
The expiration date does not establish that potency instantly becomes zero. It means the product has passed the period covered by its labeled shelf-life assurance, so a specific amount of remaining potency should not be assumed without supporting stability data.
This depends on the specific product. Current REVATIO labeling states that its reconstituted 10 mg/mL oral suspension has a 60-day shelf life and that any remaining suspension should be discarded 60 days after reconstitution.
Many current U.S. sildenafil tablet labels specify controlled room-temperature storage around 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). The instructions for the specific dispensed product remain authoritative.
No. Expiration dating is specific to the finished product, manufacturer, formulation, packaging and production lot. A date or shelf-life rule from one sildenafil product should not automatically be applied to another.